An experimental drug called CS18 weakened several cancer survival mechanisms and helped overcome treatment resistance in laboratory and animal studies. Cancer treatments can work at first, only for surviving tumor cells to find another route around the attack. Researchers at Baylor College of Medicine have developed an experimental drug called CS18 that is designed to […]This is a curated summary.